FDA Inspection 960797 — Aurobindo Pharma Ltd
The FDA completed an inspection of Aurobindo Pharma Ltd on January 29, 2016 in Medchal. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 29, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Medchal (India)